Needleye develops AI-powered robotics for needle-based procedures in oncology surgery. This telerobotic platform standardizes percutaneous procedures, enhancing precision and safety. The system reduces the learning curve for operators through robotic actuation and AI-based image processing for precise targeting.
Funding
Funding not disclosed
Founders
Product
Problem
Prostate biopsies are operator-dependent, leading to variability in accuracy and repeatability, potentially resulting in diagnostic errors and suboptimal treatment decisions. Current methods lack standardization, making it challenging for radiologists and urologists to achieve consistent and precise targeting of suspicious areas.
Solution
Needleye Robotics offers an AI-guided robotic system designed to enhance the precision, safety, and repeatability of prostate cancer biopsies and focal treatments. The system integrates AI, machine learning, and robotics to minimize diagnostic errors and standardize needle-based procedures. By automating cognitive and manual functions, the platform aims to transform the biopsy process into a more accurate and reliable robot-assisted procedure, while still allowing physicians to retain control over decision-making. The technology facilitates precise targeting, reducing identification and positioning errors, and offers a user-oriented design to shorten the learning curve for medical personnel.
Target Audience
The primary users are radiologists and urologists seeking to improve the accuracy and consistency of prostate cancer biopsies and focal treatments.
Features
- AI-powered guidance for accurate needle placement during biopsy and focal treatment.
- Robotic system designed to standardize the biopsy procedure, improving repeatability.
- User-oriented design intended to shorten the procedure learning curve for medical personnel.
- Precise targeting capabilities to minimize identification and positioning errors.
- Integration of diagnosis and focal treatment into an all-in-one solution.